Header Logo

Lisa Boggio

Concepts (156)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
7
2022
46
1.010
Why?
Purpura, Thrombotic Thrombocytopenic
2
2023
10
0.470
Why?
Hemorrhage
6
2021
81
0.370
Why?
Venous Thromboembolism
3
2020
36
0.360
Why?
Heparin
2
2020
22
0.350
Why?
Hemophilia B
3
2020
10
0.340
Why?
Anticoagulants
2
2020
90
0.330
Why?
Pipecolic Acids
1
2008
1
0.310
Why?
Factor VIII
5
2023
32
0.300
Why?
Factor IX
2
2020
7
0.300
Why?
Thrombocytopenia
1
2008
22
0.300
Why?
Thrombophilia
2
2020
6
0.240
Why?
Hemostasis
2
2016
10
0.230
Why?
Blood Coagulation Disorders
1
2004
16
0.220
Why?
Lymphoproliferative Disorders
1
2004
14
0.220
Why?
Hemostatics
1
2023
12
0.220
Why?
Recombinant Fusion Proteins
2
2020
31
0.210
Why?
Sex Chromosome Disorders
1
2022
1
0.200
Why?
Leukemia, Promyelocytic, Acute
1
2002
5
0.200
Why?
Hematologic Diseases
1
2002
11
0.200
Why?
Humans
21
2023
28408
0.180
Why?
Physical Therapists
1
2021
3
0.180
Why?
Treatment Adherence and Compliance
1
2020
7
0.170
Why?
Cardiac Surgical Procedures
1
2020
45
0.170
Why?
Serum Albumin
1
2020
24
0.170
Why?
Health Literacy
1
2021
109
0.160
Why?
Young Adult
6
2023
2069
0.160
Why?
Adolescent
6
2023
2307
0.150
Why?
Anemia, Sickle Cell
1
2018
16
0.150
Why?
Erythrocyte Transfusion
1
2018
14
0.150
Why?
Adult
10
2023
8097
0.150
Why?
Joint Diseases
1
2018
113
0.140
Why?
von Willebrand Disease, Type 1
1
2016
1
0.130
Why?
Albumins
1
2016
19
0.130
Why?
Recombinant Proteins
1
2016
213
0.130
Why?
Blood Coagulation Factors
2
2006
19
0.120
Why?
Child
4
2023
1421
0.120
Why?
Arthroplasty, Replacement, Knee
2
2012
625
0.120
Why?
Autoantibodies
2
2006
80
0.110
Why?
Autoimmune Diseases
2
2006
48
0.110
Why?
Arthroplasty, Replacement, Hip
2
2012
821
0.110
Why?
von Willebrand Factor
3
2023
10
0.100
Why?
Male
8
2023
15273
0.090
Why?
Megakaryocyte Progenitor Cells
1
2011
1
0.090
Why?
Dipeptidyl Peptidase 4
1
2011
6
0.090
Why?
Blood Loss, Surgical
2
2011
59
0.090
Why?
Practice Patterns, Physicians'
2
2020
122
0.080
Why?
Middle Aged
5
2020
9254
0.080
Why?
Arginine
1
2008
17
0.080
Why?
Thromboembolism
1
2008
17
0.080
Why?
Sulfonamides
1
2008
41
0.080
Why?
Female
6
2023
15708
0.080
Why?
Liver
1
2008
160
0.070
Why?
Clinical Trials as Topic
1
2008
239
0.070
Why?
United States
3
2018
2197
0.070
Why?
Risk Factors
3
2020
2408
0.070
Why?
Anemia, Hemolytic
1
2005
4
0.060
Why?
Paraneoplastic Syndromes
1
2006
7
0.060
Why?
Microcirculation
1
2005
29
0.060
Why?
Syndrome
1
2005
82
0.060
Why?
Fever
1
2005
36
0.060
Why?
Pneumonectomy
1
2006
77
0.060
Why?
von Willebrand Diseases
1
2005
1
0.060
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2004
3
0.060
Why?
Trophoblasts
1
2004
2
0.060
Why?
Deamino Arginine Vasopressin
1
2005
5
0.060
Why?
Adenocarcinoma
1
2006
147
0.060
Why?
Kidney Diseases
1
2005
109
0.060
Why?
Diagnosis, Differential
1
2005
372
0.060
Why?
Inflammation Mediators
1
2004
68
0.060
Why?
Quality of Life
2
2020
659
0.060
Why?
Hemorrhagic Disorders
1
2004
1
0.060
Why?
Paraproteins
1
2004
1
0.060
Why?
Fibrin
1
2004
4
0.060
Why?
Biopolymers
1
2004
6
0.060
Why?
Nervous System Diseases
1
2005
121
0.060
Why?
Autoantigens
1
2004
25
0.060
Why?
ADAMTS13 Protein
1
2023
5
0.060
Why?
Plasma
1
2023
19
0.050
Why?
Apoptosis
1
2004
205
0.050
Why?
Pregnancy
2
2020
340
0.050
Why?
Comorbidity
2
2018
500
0.050
Why?
ADAM Proteins
1
2023
41
0.050
Why?
Surveys and Questionnaires
2
2021
1216
0.050
Why?
Lipoproteins
1
2022
10
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
94
0.050
Why?
Elective Surgical Procedures
2
2012
39
0.050
Why?
Child, Preschool
1
2023
689
0.050
Why?
Hemarthrosis
1
2021
20
0.050
Why?
Heparin, Low-Molecular-Weight
1
2020
5
0.050
Why?
North America
1
2020
43
0.040
Why?
Aged
3
2020
9262
0.040
Why?
Lung Neoplasms
1
2006
553
0.040
Why?
Infusions, Intravenous
1
2020
53
0.040
Why?
Pilot Projects
1
2021
439
0.040
Why?
Hemoglobin, Sickle
1
2018
1
0.040
Why?
Iron Overload
1
2018
2
0.040
Why?
Blood Viscosity
1
2018
10
0.040
Why?
Follow-Up Studies
1
2023
1858
0.040
Why?
Retrospective Studies
2
2023
3609
0.040
Why?
Disease Management
1
2018
114
0.040
Why?
Anxiety
1
2018
161
0.030
Why?
Administration, Intravenous
1
2016
23
0.030
Why?
Comparative Genomic Hybridization
1
2016
4
0.030
Why?
Blood Coagulation Tests
1
2016
11
0.030
Why?
Demography
1
2016
73
0.030
Why?
Sequence Analysis, DNA
1
2016
58
0.030
Why?
Genetic Variation
1
2016
97
0.030
Why?
Dose-Response Relationship, Drug
1
2016
351
0.030
Why?
Phenotype
1
2016
311
0.030
Why?
Cross-Sectional Studies
1
2018
932
0.030
Why?
Aged, 80 and over
1
2004
4853
0.030
Why?
Depression
1
2018
452
0.030
Why?
Patient Reported Outcome Measures
1
2018
506
0.030
Why?
Treatment Outcome
2
2016
3615
0.030
Why?
Early Ambulation
1
2011
17
0.020
Why?
Intermittent Pneumatic Compression Devices
1
2011
7
0.020
Why?
Ultrasonography, Doppler, Duplex
1
2011
15
0.020
Why?
Vena Cava Filters
1
2011
8
0.020
Why?
Anesthesia, Epidural
1
2011
21
0.020
Why?
Cell Division
1
2011
83
0.020
Why?
Venous Thrombosis
1
2011
46
0.020
Why?
Flow Cytometry
1
2011
116
0.020
Why?
Prospective Studies
1
2016
1805
0.020
Why?
Ultrasonography
1
2012
243
0.020
Why?
Mice, Knockout
1
2011
316
0.020
Why?
Practice Guidelines as Topic
1
2012
320
0.020
Why?
Multivariate Analysis
1
2011
331
0.020
Why?
Mice, Inbred C57BL
1
2011
435
0.020
Why?
Mice
1
2011
1461
0.020
Why?
Partial Thromboplastin Time
1
2006
4
0.020
Why?
Carboplatin
1
2006
24
0.020
Why?
Paclitaxel
1
2006
44
0.020
Why?
Immunoglobulins, Intravenous
1
2006
19
0.020
Why?
Cyclophosphamide
1
2006
51
0.020
Why?
Hyperglycemia
1
2006
32
0.020
Why?
Prednisone
1
2006
65
0.020
Why?
Postoperative Complications
1
2011
931
0.020
Why?
Bleeding Time
1
2005
1
0.020
Why?
Drug Evaluation
1
2005
20
0.020
Why?
Pre-Eclampsia
1
2004
7
0.010
Why?
Sampling Studies
1
2004
29
0.010
Why?
Placenta
1
2004
10
0.010
Why?
Combined Modality Therapy
1
2006
307
0.010
Why?
Administration, Intranasal
1
2005
27
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
97
0.010
Why?
Immunosuppressive Agents
1
2006
140
0.010
Why?
Neoplasm Staging
1
2006
371
0.010
Why?
Gestational Age
1
2004
88
0.010
Why?
Reference Values
1
2004
194
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2006
241
0.010
Why?
Cells, Cultured
1
2004
539
0.010
Why?
Cytokines
1
2004
230
0.010
Why?
Diabetes Mellitus, Type 2
1
2006
191
0.010
Why?
Sensitivity and Specificity
1
2004
517
0.010
Why?
Animals
1
2011
3780
0.010
Why?
Boggio's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (156)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_